New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Green Thumb Industries Inc.
GTII.CN
Shape
US Flag

CNQ

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

15.31CAD
Shape0.23 ( 1.53%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-70%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

29%

Quote Panel

Shape
Updated October 28, 2024
1W -0.39 % 1M 8.67 % 3M -2.11 % 1Y 40.79 %

Key Metrics

Shape
  • Market Cap

    3.54B


  • Shares Outstanding

    236.72M


  • Share in Float

    213.34M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    15.31


  • Average Volume

    113993


  • Beta

    1.448


  • Range

    10.44-21.5


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.gtigrows.com


  • Sector

    Healthcare


Fundamentals

Shape

48.76x

P/E Ratio

2.30x

P/S Ratio

1.49x

P/B Ratio

0.3

Debt/Equity

5.9%

Net Margin

$0.4

EPS

How GTII.CN compares to sector?

P/E Ratio

Relative Strength

Shape

GTII.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape499%

2025-Revenue

$0.35

Shape301%

2025-EPS

$400M

Shape316%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-50%

0.04
vs 0.08

Q4.22

arrow
arrow

-50%

0.05
vs 0.1

Q1.23

arrow
arrow

-67%

0.04
vs 0.12

Q2.23

arrow
arrow

-50%

0.05
vs 0.1

Q3.23

arrow
arrow

+25%

0.05
vs 0.04

Q4.23

arrow
arrow

-80%

0.01
vs 0.05

Q1.24

arrow
arrow

+225%

0.13
vs 0.04

Q2.24

arrow
arrow

+147%

0.12
vs 0.05

Q3.24

arrow
arrow

+29%

0.06
vs 0.05

Q4.24

arrow
arrow

+608%

0.07
vs 0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+12%

261.2M  vs 233.7M

Q4.22

arrow
arrow

+6%

259.3M  vs 243.6M

Q1.23

arrow
arrow

+2%

248.5M  vs 242.6M

Q2.23

arrow
arrow

-1%

252.4M  vs 254.3M

Q3.23

arrow
arrow

+5%

275.4M  vs 261.2M

Q4.23

arrow
arrow

+7%

278.2M  vs 259.3M

Q1.24

arrow
arrow

+11%

275.8M  vs 248.5M

Q2.24

arrow
arrow

+11%

280.1M  vs 252.4M

Q3.24

arrow
arrow

+39%

382.4M  vs 275.4M

Q4.24

arrow
arrow

+44%

401.1M  vs 278.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.01

Q4.22

arrow
arrow

-3%

-0.03
vs 0.01

Q1.23

arrow
arrow

+1%

0.01
vs -0.03

Q2.23

arrow
arrow

+1%

0.01
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.01

Q1.24

arrow
arrow

+2%

0.02
vs 0

Q2.24

arrow
arrow

+1%

0.01
vs 0.02

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News